Friday, November 27, 2020 3:25:59 PM
hopester..Eklab...I have this discussion 15-20 times a day..!!!
For my under 70 yrs patients..In good health..With few co-morbidity’s..I Advise I’m NOT TAKING THE Vaccine till possibly end of next year or later..Depending upon what I observe till then..!!! I let them know the WEIGHT OF THE AMERICAN GOVERNMENT..THE FDA..DR FAUCI..AND THE VAST MAJORITY OF THE MEDICAL COMMUNITY IS BEHIND THE VACCINE..!!! I give my reasoning as to my hesitation in supporting the same..It is up to the patient’s to decide..Knowing both sides of the coin..!!!
For my patients over 70 yrs..Having significant Co-Morbidity’s..I advice the same.... Other than..THEIR CHANCES OF A NEGATIVE OUTCOME..IN CASE OF A CORONA INFECTION...IS EXTREMELY HIGH..!!! And that they should weigh this in their decision to TAKE OR NOT TAKE THE VACCINE...NOW...!!!
All my patients are on Zinc 50 mg..Vit D5000 units.. Quercetin..CoQ10..!!!
So far ..So good..!!!
For my under 70 yrs patients..In good health..With few co-morbidity’s..I Advise I’m NOT TAKING THE Vaccine till possibly end of next year or later..Depending upon what I observe till then..!!! I let them know the WEIGHT OF THE AMERICAN GOVERNMENT..THE FDA..DR FAUCI..AND THE VAST MAJORITY OF THE MEDICAL COMMUNITY IS BEHIND THE VACCINE..!!! I give my reasoning as to my hesitation in supporting the same..It is up to the patient’s to decide..Knowing both sides of the coin..!!!
For my patients over 70 yrs..Having significant Co-Morbidity’s..I advice the same.... Other than..THEIR CHANCES OF A NEGATIVE OUTCOME..IN CASE OF A CORONA INFECTION...IS EXTREMELY HIGH..!!! And that they should weigh this in their decision to TAKE OR NOT TAKE THE VACCINE...NOW...!!!
All my patients are on Zinc 50 mg..Vit D5000 units.. Quercetin..CoQ10..!!!
So far ..So good..!!!
Recent CYDY News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
